Pyrazinamide
10 NDCs across 4 manufacturers|10 Generic,0 Brand
Pyrazinamide is used to treat tuberculosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product the first generic was approved Jan 1, 1982. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $600K on Pyrazinamide across 2,444 claims for 1,344 beneficiaries.
Pyrazinamide is available as 10 NDCs from 4 manufacturers (10 generic, 0 brand), with NADAC prices from $1.31 to $1.31 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
10G / 0B
Manufacturers
4
competing in market
Price Spread
$1.31 – $1.31
per EA
7d Activity
avg -1.5% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Hikma Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antimycobacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing PYRAZINAMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
PYRAZINAMIDE 500 MG TABLET | $1.3081 per EA | -1.47% |
Frequently Asked Questions
What is Pyrazinamide used to treat?
Pyrazinamide is used to treat tuberculosis, per the National Library of Medicine's MED-RT classification.
When did Pyrazinamide become available as a generic?
FDA approved the first generic Pyrazinamide (ANDA) on Jan 1, 1982. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Pyrazinamide?
In 2024, Medicare Part D spent $600K on Pyrazinamide across 2,444 claims for 1,344 beneficiaries.
How many Pyrazinamide products are on the market?
The Pyrazinamide drug market contains 10 NDCs from 4 manufacturers — 10 generic and 0 brand products.
What is the price range for Pyrazinamide?
NADAC reference prices for Pyrazinamide range from $1.3081 to $1.3081 per EA.
Which manufacturers make Pyrazinamide?
4 manufacturers list Pyrazinamide in NADAC. Ranked by number of NDCs, the largest are Hikma Pharmaceuticals USA Inc. (4), Novitium Pharma LLC (3), Macleods Pharmaceuticals Limited (2), American Health Packaging (1).
How has the price of Pyrazinamide changed recently?
Over the past 7 days, 0 Pyrazinamide NDCs rose and 10 fell, with a market-wide average change of -1.5%.